Table 2.
Virologic, treatment, and education factors associated with age acceleration measures
| Outcome: AgeAccelerationResidual. R^2=0.088 |
Outcome: EEAA. R.square=0.173 | |||||
|---|---|---|---|---|---|---|
|
| ||||||
| Covariate | Coef | Std. Error |
P- value |
Coef | Std. Error |
P- value |
|
| ||||||
| Detectable.HIV.viral.load (VL > 50) | 3.71E-01 | 6.56E-01 | 5.73E-01 | 1.50E+00 | 1.22E+00 | 2.22E-01 |
| Current CD4 T count | −1.14E-03 | 5.19E-04 | 2.97E-02 | −3.38E-03 | 9.69E-04 | 6.03E-04 |
| Race (Coloured) | 3.11E-01 | 8.84E-01 | 7.26E-01 | −3.24E+00 | 1.65E+00 | 5.11E-02 |
| ARV duration | −5.53E-02 | 9.94E-02 | 5.79E-01 | −2.27E-01 | 1.86E-01 | 2.23E-01 |
| ARV line | 1.16E+00 | 4.90E-01 | 1.90E-02 | 2.31E+00 | 9.15E-01 | 1.23E-02 |
| Education (Highest Grade) | −2.99E-01 | 2.23E-01 | 1.81E-01 | −8.39E-01 | 4.16E-01 | 4.50E-02 |
| Repeated Grade (Yes) | −7.44E-01 | 5.02E-01 | 1.40E-01 | −2.61E-01 | 9.38E-01 | 7.81E-01 |